Navigation Links
High-risk Patients Need Better Guidance on What is and Isnt a Heart Attack

Varying advice means patients at high-risk of having a heart attack are unclear about when symptoms are potentially life threatening and when they should call an ambulance , argue a group of heart specialists in this weeks BMJ.

At least 70% of people who die from coronary heart disease have had previous heart problems.

Yet recent data from the British Heart Foundation shows that 40% of the general population would not immediately call an ambulance during a suspected heart attack and the greatest delays in calling 999 are among the high-risk group.

This implies, say Dr Khavandi and colleagues, that high-risk patients do not seem to be receiving clear effective guidance from their doctors.

One of the symptoms of a heart attack is angina. Yet angina can also be a stable condition which lasts only a few minutes and can be controlled by medication. The writers say ideally they would like patients to be able to tell the difference between the two types but in reality they do not.

In particular, high-risk patients with ischaemic heart disease (IHD) - which causes a reduction in the blood supply to the heart, usually felt as angina - are given varying advice from doctors, health organisations and drug manufacturers about how to use the drugs (sublingual nitrate GTN sprays) prescribed to relieve the condition.

The advice also varies on when they should call an ambulance. The British Heart Foundation advises patients with known IHD to call an ambulance if chest pains last longer than 15 minutes and to use their spray three times during that period.

The American College of Cardiology recommends one spray and 5 minutes before calling an ambulance.

Manufacturers instructions are sometimes non-specific, for example, recommending no more than 3 doses and 15 minutes between treatments leaving it to the prescribing doctor to guide the patient.

Waiting 15 min utes, say the writers, could be too long for some patients. One study has shown that the median time from onset of symptoms to cardiac arrest is ten minutes.

They recommend patients and their relatives should be explicitly primed to recognise high-risk features of chest pain. They advise patients at high-risk or with IHD to carry a GTN spray with them at all times, to take two metered doses immediately if they get chest pain and to wait 5 minutes before calling an ambulance. They should not waste time by calling a friend or relative first and should not drive themselves to hospital.


'"/>




Related medicine news :

1. New Placenta Screening for High-risk Pregnancies
2. Aspirin may Help to Prevent Colon Cancer in High-risk Individuals
3. High-risk Sexual Behavior Adolescents Attract Peers With Similar Attitudes
4. One in Three Heart Attack Patients Have No Chest Pains
5. Amphetamines Help Recovery of Stroke Patients
6. Painkillers Do Not Shorten Dying Patients Lives
7. Patients With Filariasis More Prone To HIV Infection
8. Glivec - New Hope For CMC Patients
9. Patients often assume wrongly that they are allergic to penicillin
10. New FDA Approved Drug NATRECOR For Heart Failure Patients
11. Hemochromatosis Patients Blood is Safe
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/28/2017)... ... June 28, 2017 , ... Guide to FDA and EU Medical Device Regulations: ... which side of the Atlantic devicemakers do business, this fully updated and expanded guide ... In addition to the full text of the FDA’s regulations in 21 CFR Parts ...
(Date:6/28/2017)... ... ... remote control has seen the never-ending twists on the house flipping show genre. The shows ... time. But what about the buyers of the flipper's flip. , Here is ... An email recently sent to Gary Case said, “Just closed on a home on ...
(Date:6/28/2017)... , ... June 28, 2017 , ... David B. Sosin, a founding partner ... took over the post of 2nd Vice President for the Illinois State Bar Association ... as the ISBA’s 3rd Vice President in 2016 following a state-wide election and served in ...
(Date:6/28/2017)... FL (PRWEB) , ... June 28, 2017 , ... American ... an upcoming episode of the award winning television series, scheduled to broadcast fourth quarter ... Line Seeds originated as a regional supplier of garden pea seed. As demand grew, ...
(Date:6/28/2017)... ... 28, 2017 , ... Canadian Zeolite Corp. (the “Company”) (TSX.V: ... study conducted by the University of Saskatchewan in partnership with PotashCorp, Agrium and ... groundwater. As a part of the study, batch adsorption experiments were conducted with ...
Breaking Medicine News(10 mins):
(Date:6/9/2017)... , June 9, 2017 AirXpanders, Inc. (ASX: ... on the design, manufacture, sale and distribution of the ... the progress of its commercial roll-out in ... in more than one hundred (100) medical institutions and ... AeroForm offers a needle-free alternative for women who choose ...
(Date:6/8/2017)... 2017  StatLab Medical Products ("StatLab" or ... of diagnostic supplies for the anatomic pathology ... Company LP ("Cressey & Company"), a healthcare-focused ... investment in the Company. Cressey & Company ... selling shareholder, Prairie Capital, L.P., with certain ...
(Date:6/5/2017)... CINCINNATI , June 5, 2017 The ... a brand of Diplomat Pharmacy, Inc. (NYSE: DPLO), has been ... Cincinnati Enquirer . Results are based on ... specializing in organizational health and workplace improvement. The survey measures ... ...
Breaking Medicine Technology: